| Ticker Details |
|
Olema Pharmaceuticals, Inc.
|
| IPO Date: |
November 16, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.19B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.52 | 3.90%
|
| Avg Daily Range (30 D): |
$0.30 | 2.00%
|
| Avg Daily Range (90 D): |
$0.54 | 2.87%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.65M |
| Avg Daily Volume (30 D): |
.78M |
| Avg Daily Volume (90 D): |
1.16M |
| Trade Size |
| Avg Trade Size (Sh.): |
85 |
| Avg Trade Size (Sh.) (30 D): |
55 |
| Avg Trade Size (Sh.) (90 D): |
67 |
| Institutional Trades |
| Total Institutional Trades: |
1,203 |
| Avg Institutional Trade: |
$1.98M |
| Avg Institutional Trade (30 D): |
$2.03M |
| Avg Institutional Trade (90 D): |
$2.51M |
| Avg Institutional Trade Volume: |
.14M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.63M |
| Avg Closing Trade (30 D): |
$2.24M |
| Avg Closing Trade (90 D): |
$3.45M |
| Avg Closing Volume: |
176.05K |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-2.03
|
$-.52
|
$-.51
|
|
Diluted EPS
|
$-2.03
|
$-.52
|
$-.51
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-185.15M
|
$-53.09M
|
$-46.06M
|
|
Operating Income / Loss
|
$-201.81M
|
$-57.99M
|
$-50.08M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$1.91M
|
$4.25M
|
$13.04M
|
|
PE Ratio
|
|
|
|
|
|
|